ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 340

Myeloid Deletion of SIRT1 Aggravates Inflammatory Arthritis Via Nuclear Factor-Kappab Activation in Animal Model of Rheumatoid Arthritis

Sang-il Lee and Yun-Hong Cheon, Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, rheumatoid arthritis (RA) and rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis: Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: The nuclear factor-kappaB (NF-kB) activation plays a pivotal role and macrophages are of central importance in the pathogenesis of rheumatoid arthritis (RA). The SirT1, which is a class III histone deacetylase, deacetylates acetyl group of various transcription factors including NF-kB and modulates their functions, suggesting that myeloid deletion of SirT1 may affect inflammatory arthritis such as RA. The study was performed to assess the function of SirT1 in inflammation and joint destruction in in vivo model of RA.

Methods: The mice with myeloid cells-specific deletion of SirT1 (M-SirT1 KO) were generated by using the loxP/Cre recombinase system. K/BxN serum transfer arthritis was induced in M-SirT1 KO mice and their age-matched littermate loxP controls (Sirt1loxP/loxPLysM-Cre-/-) by injection of K/BxN serum. Arthritis severity was assessed by clinical and histopathologic scoring. The levels of inflammatory cytokines in the joints and serum were measured by ELISA. The NF-kB acetylation, activation, and cytokine/chemokine expression were assessed by Western, EMSA, and ELISA, respectively, using bone marrow-derived macrophages (BMMs).

Results: M-SirT1 KO showed severe form of inflammatory arthritis accompanied by aggravated histopathologic findings including synovial inflammation, bone erosion, and cartilage damage. These effects were paralleled by increased F4/80+ macrophage infiltration into synovium and increased levels of IL-1, IL-6, and RANKL. TNF-α stimulated M-SirT1 KO BMMs displayed hyperacetylated p65 and increased NF-kB binding activity than controls, resulting in increased transcriptional activation of proinflammatory target genes.

Conclusion: This study demonstrates that SIRT1, in macrophages, functions to inhibit NF-kB-mediated transcription, implying that myeloid cell-specific modulation of SirT1 may be beneficial in the treatment of inflammation arthritis such as RA.


Disclosure:

S. I. Lee,
None;

Y. H. Cheon,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/myeloid-deletion-of-sirt1-aggravates-inflammatory-arthritis-via-nuclear-factor-kappab-activation-in-animal-model-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology